Glueck, Olaf M. http://orcid.org/0000-0003-2380-4223
Liang, Xiaoling http://orcid.org/0000-0002-0572-5188
Badell, Irina http://orcid.org/0000-0002-6629-3542
Wratil, Paul R. http://orcid.org/0000-0003-0942-0637
Graf, Alexander
Krebs, Stefan
Blum, Helmut
Hellmuth, Johannes C. http://orcid.org/0000-0001-8409-3037
Scherer, Clemens
Hollaus, Alexandra
Spaeth, Patricia M.
Karakoc, Burak
Fuchs, Thimo
Zimmermann, Julia
Kauke, Teresa
Moosmann, Andreas
Keppler, Oliver T.
Schneider, Christian
Muenchhoff, Maximilian http://orcid.org/0000-0001-7016-0470
Funding for this research was provided by:
Free State of Bavaria, Germany (BayVOC, BayVOC)
Ludwig-Maximilians-Universität München
Article History
Received: 26 July 2023
Accepted: 12 October 2023
First Online: 3 November 2023
Declarations
:
: The authors have no competing interests to declare that are relevant to the content of this article.
: This study was approved by the local ethics committee (Institutional Review Board) (No: 20-245). Furthermore, all patients were recruited into the COVID-19 Registry of the LMU University Hospital Munich (CORKUM) under the WHO trial ID DRKS00021225. All patients gave their written consent to participate in this study and for any resulting publication. This study was conducted following the guidelines of the declaration of Helsinki and the Rules of Good Scientific Practice (GSP) of the Ludwig Maximilian University Munich.